The heparinases from Flavobacterium heparinum are lyases that specifically cleave heparin-like glycosaminoglycans. Previously, amino acids located in the active site of heparinase I have been identified and mapped. In an effort to further understand the mechanism by which heparinase I cleaves its polymer substrate, we sought to understand the role of calcium, as a necessary cofactor, in the enzymatic activity of heparinase I. Specifically, we undertook a series of biochemical and biophysical experiments to answer the question of whether heparinase I binds to calcium and, if so, which regions of the protein are involved in calcium binding. Using the fluorescent calcium analog terbium, we found that heparinase I tightly bound divalent and trivalent cations. Furthermore, we established that this interaction was specific for ions that closely approximate the ionic radius of calcium. Through the use of the modification reagents N-ethyl-5-phenylisoxazolium-3-sulfonate (Woodward's reagent K) and 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride, we showed that the interaction between heparinase I and calcium was essential for proper functioning of the enzyme. Preincubation with either calcium alone or calcium in the presence of heparin was able to protect the enzyme from inactivation by these modifying reagents. In addition, through mapping studies of Woodward's reagent Kmodified heparinase I, we identified two putative calcium-binding sites, CB-1 (Glu 207 -Ala 219 ) and CB-2 (Thr 373 -Arg 384 ), in heparinase I that not only are specifically modified by Woodward's reagent K, leading to loss of enzymatic activity, but also conform to the calciumcoordinating consensus motif.Heparin-like glycosaminoglycans, such as heparin and heparan sulfate, are acidic polysaccharides that play a role in many central biological processes, such as cell proliferation and signaling (1, 2). However, attempts to determine whether heparinlike glycosaminoglycans are involved in a particular biological process have been hampered by the lack of tools available to study these substrates.One such tool, under development in our laboratory, is the heparinases, bacterially derived lyases. Heparinase I from Flavobacterium heparinum is a 43-kDa enzyme that cleaves primarily heparin-like regions of heparin-like glycosaminoglycans (i.e. regions containing a high degree of sulfation with primarily iduronic acid as the uronic acid component) (3, 4). Heparinase I has been used in a variety of circumstances to highlight the importance of heparin-like glycosaminoglycans in such diverse biological processes as angiogenesis (5) and development (6).To extend the capabilities of the heparinases, we have undertaken a series of biochemical studies aimed at identifying important functional residues as well as elucidating the enzyme's mode of action. Through a combination of chemical modification, proteolytic mapping, and site-directed mutagenesis, we have identified Cys 135 (7), His 203 (8), and Lys 199 (9) as amino acid residues important for heparinase ...